Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1- and PRKN-linked Parkinson's disease
Joanne Trinh, Andrew A. Hicks, Inke Regina König, Sylvie Delcambre, Theresa Lüth, Susen Schaake, Kobi Wasner, Jenny Ghelfi, Max Borsche, Carles Vilariño‐Güell, Fayçel Hentati, Elisabeth Luisa Germer, Peter Bauer, Masashi Takanashi, Vladimir Kostić, , Anne Grünewald
The paper identifies mitochondrial DNA heteroplasmy as a marker distinguishing disease manifestation in PINK1/PRKN mutation carriers.
Brain · Dec 7, 2022Peer-reviewedGenetic & Genomic Medicine